Sartorius BIA Separations develops and manufactures market-leading CIM® monolithic chromatographic columns for the purification and analysis of large biomolecules, such as viruses, plasmids, and mRNA, which are applied in cell and gene therapies. We also offer the highly versatile PATfix™ system for producing analytical gradient separations. Our ongoing mission is to develop and produce CIM® monoliths of the highest quality and provide superior research and method development services for our customers.

Our Cornerstone® Biomanufacturing Development Services are the result of more than 25 years of hands-on experience with the most challenging biopharmaceutical products and offer a comprehensive approach of integrated process development solutions and novel technology designed to improve the robustness and yield of large biomolecules production while improving the safety of therapeutic products.

Sartorius BIA's technology for manufacturing-scale purification is already used in the production of the first commercialized advanced therapeutics, but we also have a keen presence with novel drug candidates in the clinical pipeline.